Ancora Advisors LLC Buys 135,482 Shares of Kenvue Inc. (NYSE:KVUE)

Ancora Advisors LLC grew its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 20.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 786,070 shares of the company's stock after acquiring an additional 135,482 shares during the period. Ancora Advisors LLC's holdings in Kenvue were worth $16,783,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Price T Rowe Associates Inc. MD raised its stake in Kenvue by 3.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock valued at $5,249,665,000 after purchasing an additional 8,211,748 shares during the period. Vanguard Group Inc. raised its position in Kenvue by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company's stock valued at $4,665,908,000 after buying an additional 1,636,741 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in Kenvue by 12.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company's stock worth $2,085,070,000 after acquiring an additional 10,682,003 shares in the last quarter. Geode Capital Management LLC boosted its position in Kenvue by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company's stock worth $980,989,000 after acquiring an additional 1,391,854 shares during the period. Finally, Franklin Resources Inc. grew its stake in Kenvue by 61.5% during the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company's stock valued at $912,059,000 after acquiring an additional 16,269,721 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

KVUE has been the subject of a number of research analyst reports. Canaccord Genuity Group increased their price target on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research report on Wednesday, March 5th. Evercore ISI started coverage on shares of Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price for the company. Citigroup boosted their price target on shares of Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a report on Monday, April 14th. Barclays dropped their price target on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Monday, April 14th. Finally, Royal Bank of Canada reissued a "sector perform" rating and set a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $24.42.

Kenvue Stock Performance

Shares of NYSE:KVUE traded down $0.35 during trading on Monday, reaching $23.63. The stock had a trading volume of 23,279,545 shares, compared to its average volume of 17,062,863. The stock has a fifty day simple moving average of $23.10 and a two-hundred day simple moving average of $22.53. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The firm has a market capitalization of $45.34 billion, a price-to-earnings ratio of 44.58, a P/E/G ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be given a dividend of $0.205 per share. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.47%. Kenvue's dividend payout ratio is presently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.